|
Volumn 13, Issue 5, 2002, Pages 491-495
|
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies
a a a a a a a a a |
Author keywords
Cisplatin; Mitoxantrone; Palliative chemotherapy; Salivary gland carcinoma
|
Indexed keywords
CISPLATIN;
CREATININE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
MITOXANTRONE;
ANTINEOPLASTIC AGENT;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
INFECTION;
LEUKOPENIA;
METASTASIS;
NAUSEA;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENT CANCER;
SALIVARY GLAND CARCINOMA;
STOMATITIS;
THROMBOCYTOPENIA;
VOMITING;
ADJUVANT CHEMOTHERAPY;
CHEMICALLY INDUCED DISORDER;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
LUNG TUMOR;
MIDDLE AGED;
NEUTROPENIA;
PALLIATIVE THERAPY;
PATHOLOGY;
SALIVARY GLAND TUMOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
HUMAN;
LUNG NEOPLASMS;
MIDDLE AGE;
MITOXANTRONE;
NAUSEA;
NEOPLASM RECURRENCE, LOCAL;
NEUTROPENIA;
PALLIATIVE CARE;
SALIVARY GLAND NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
EID: 0035987075
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200206000-00007 Document Type: Article |
Times cited : (23)
|
References (18)
|